文献速递临床免疫临床生化

自动化质谱系统用于单克隆免疫球蛋白测量与分型的性能评估

Performance evaluation of an automated mass spectrometry system for the measurement and isotyping of monoclonal immunoglobulins.
PubMed 文献 · Clin Chim Acta · 2026-02-27

评估EXENT分析仪(EXENT检测)自动化MALDI-ToF质谱免疫分析检测单克隆免疫球蛋白的性能,在3个实验室的718例单克隆丙种球蛋白病患者、417例疾病对照和364例健康样本中与电泳方法比较。结果显示EXENT检测的检出率高于血清蛋白电泳(92.6% vs 85.1%),浓度相关性好(r=0.874),阳性样本同种型一致率97%。

要点

  • EXENT质谱免疫分析可报告M蛋白的存在、浓度、同种型和质荷比。
  • EXENT检测在单克隆丙种球蛋白病患者中检出率92.6%,高于血清蛋白电泳的85.1%。
  • EXENT检测与血清蛋白电泳和免疫固定电泳在M蛋白检测和单克隆丙种球蛋白病评估上具有可比性。

核心结论

  • EXENT检测与血清蛋白电泳和免疫固定电泳在M蛋白检测和单克隆丙种球蛋白病评估方面具有可比性。

研究设计与样本

  • 在3个实验室中,使用电泳方法或EXENT检测对718例各种单克隆丙种球蛋白病患者、417例疾病对照和364例健康样本中的M蛋白进行评估。
  • 按照CLSI指南建立EXENT检测的精密度、线性、测量区间下限(LLMI)和干扰性能。

主要发现

  • EXENT检测在正常多克隆水平样本中IgG、IgA和IgM的测量下限分别为0.308 g/L、0.073 g/L和0.054 g/L。
  • 所有同种型的总不精密度范围为3.7%至12.8%,实验室间不精密度为5.1%至14.3%。
  • 治疗性单克隆抗体被标记为内源性IgG kappa M蛋白,当满足m/z阈值时未显示干扰。
  • EXENT检测在92.6%的单克隆丙种球蛋白病患者中检测到M蛋白,而血清蛋白电泳(SPE)为85.1%。
  • EXENT检测与电泳方法的浓度相关性强(r=0.874),阳性样本的同种型一致率为97%。

关键数值与推荐

  • 临床临界值设定为IgG 0.359 g/L、IgA 0.325 g/L、IgM 0.197 g/L。

临床怎么用

  • EXENT检测可用于单克隆免疫球蛋白的测量和分型,作为电泳技术的自动化替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Monoclonal proteins are detected using electrophoretic techniques and used to help diagnose plasma cell dyscrasias. The Immunoglobulin Isotypes (GAM) for the EXENT® analyser (EXENT assay) is an automated MALDI-ToF mass spectrometry immunoassay, designed for use with Optilite® turbidimetric assays for the identification and measurement of monoclonal immunoglobulins (M-proteins). The assay reports M-protein presence, concentration, isotype, and mass/charge ratio (m/z). METHODS: The EXENT assay precision performance, linearity, lower limit of the measuring interval (LLMI) and interference were established per CLSI guidelines. M-proteins were evaluated using electrophoretic methods or the EXENT assay in clinical samples from 718 patients with various monoclonal gammopathies, 417 disease controls and 364 healthy samples at 3 different laboratories. RESULTS: The EXENT assay demonstrated a lower measuring limit of 0.308 g/L, 0.073 g/L and 0.054 g/L for IgG, IgA, and IgM in samples with normal polyclonal levels. Total imprecision ranged from 3.7 to 12.8% across all isotypes, and between-laboratory was 5.1-14.3%. Therapeutic monoclonal antibodies were flagged from endogenous IgG kappa M-proteins and showed no interference when m/z thresholds were met. Clinical cut-offs were established at 0.359 g/L (IgG), 0.325 g/L (IgA), and 0.197 g/L (IgM). The EXENT assay detected M-proteins in 92.6% of monoclonal gammopathy patients versus 85.1% by serum protein electrophoresis (SPE), with strong concentration correlations (r = 0.874) and 97% isotype concordance in positive samples. CONCLUSIONS: The EXENT assay demonstrated comparability to SPE and immunofixation electrophoresis (IFE) for M-protein detection and the evaluation of monoclonal gammopathies.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Ashby J, McEntee D, Sakrikar D, et al. Performance evaluation of an automated mass spectrometry system for the measurement and isotyping of monoclonal immunoglobulins. Clin Chim Acta. 2026. PMID: 41765198. doi:10.1016/j.cca.2026.120930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。